AH2I Medical Group Ltd.

About

Funding history · 1 round · — total

Q&A

What is AH2I Medical Group Ltd. developing?

AH2I Medical Group Ltd. is developing a dual-barrel injection device designed to control the flow of high-viscosity fluids through a single needle.

What are the primary applications of AH2I Medical Group's technology?

The technology has applications in various medical fields, including aesthetics (dermal fillers), orthopaedics (viscosupplementation), spine surgery (bone cement), and self-injected biologics.

When was AH2I Medical Group Ltd. founded?

AH2I Medical Group Ltd. was founded in 2024.

What type of funding has AH2I Medical Group Ltd. received?

In 2024, AH2I Medical Group Ltd. received a Grant from the Israel Innovation Authority.

Who are the co-founders of AH2I Medical Group Ltd.?

The co-founders of AH2I Medical Group Ltd. are Hertsel Adhoute (Co-founder & CEO), Inna Kogan (Co-founder & Medical Adviser), and Alex Liberzon (Co-founder & CSO).

What is the primary sector of AH2I Medical Group Ltd.?

AH2I Medical Group Ltd.'s primary sector is Medical Devices.

Does AH2I Medical Group Ltd. hold any patents for its technology?

Yes, AH2I Medical Group Ltd. holds a patent family for its dual-barrel injection device technology.

Team · 4

Hertsel Adhoute

Founder · Co-founder & CEO

Inna Kogan

Founder · Co-founder & Medical Adviser

Alex Liberzon

Founder · Co-founder & CSO

Hugues Cartier

Medical Director

Sectors & technology